Loading...
Market
Will a new therapeutic drug for Monkeypox based on the identified DNA sequences enter clinical trials by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Clinical trial registries or announcements from pharmaceutical companies
Story
JNCASR Scientists Identify New Detection Method and DNA Sequences for Monkeypox Virus (MPV) with Therapeutic Implications
Nov 22, 2024, 09:51 AM
Scientists from the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) have discovered a new method for detecting the Monkeypox virus (MPV). This research aims to enhance diagnostic tools for the infection and explore therapeutic implications. The findings, announced by India's Ministry of Science and Technology, highlight the identification of specific DNA sequences within the MPV genome, which could lead to significant advancements in understanding the virus's virology.
View original story
Similar markets
Yes • 50%
No • 50%
ACAM2000 • 25%
JYNNEOS • 25%
MVA-BN • 25%
Other • 25%
Yes • 50%
No • 50%
Vaccine • 25%
Antiviral treatment • 25%
Both • 25%
Neither • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%